WEST PHARMACEUTICAL SVSC ($WST) posted quarterly earnings results on Thursday, April 24th. The company reported earnings of $1.45 per share, beating estimates of $1.24 by $0.21. The company also reported revenue of $698,000,000, beating estimates of $691,687,188 by $6,312,812.
You can see Quiver Quantitative's $WST stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
WEST PHARMACEUTICAL SVSC Insider Trading Activity
WEST PHARMACEUTICAL SVSC insiders have traded $WST stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $WST stock by insiders over the last 6 months:
- CHARLES WITHERSPOON (VP & Treasurer) has made 0 purchases and 2 sales selling 703 shares for an estimated $218,211.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
WEST PHARMACEUTICAL SVSC Hedge Fund Activity
We have seen 344 institutional investors add shares of WEST PHARMACEUTICAL SVSC stock to their portfolio, and 356 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- APG ASSET MANAGEMENT N.V. removed 871,445 shares (-37.7%) from their portfolio in Q4 2024, for an estimated $285,450,524
- PRICE T ROWE ASSOCIATES INC /MD/ removed 736,159 shares (-58.4%) from their portfolio in Q4 2024, for an estimated $241,136,242
- VAN ECK ASSOCIATES CORP added 676,167 shares (+5074.0%) to their portfolio in Q4 2024, for an estimated $221,485,262
- CITADEL ADVISORS LLC added 622,752 shares (+1294.0%) to their portfolio in Q4 2024, for an estimated $203,988,645
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 577,417 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $189,138,712
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 563,705 shares (+731.8%) to their portfolio in Q4 2024, for an estimated $184,647,209
- PROSHARE ADVISORS LLC removed 533,588 shares (-48.0%) from their portfolio in Q4 2024, for an estimated $174,782,085
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
WEST PHARMACEUTICAL SVSC Congressional Stock Trading
Members of Congress have traded $WST stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $WST stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 02/25.
- REPRESENTATIVE JARED MOSKOWITZ has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 02/13, 11/08.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
WEST PHARMACEUTICAL SVSC Analyst Ratings
Wall Street analysts have issued reports on $WST in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 01/08/2025
- Jefferies issued a "Buy" rating on 11/19/2024
To track analyst ratings and price targets for WEST PHARMACEUTICAL SVSC, check out Quiver Quantitative's $WST forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
